Updated: Oct 1, 2009
A high-pressure injection injury should be considered a potential surgical emergency. Immediate decompression and thorough cleansing of the offending material from the tissue is required to preserve optimal function.
Acute injury is caused by introduction of a foreign material, under high pressure between 2,000 and 10,000 psi, into the poorly distensible digital or palmar tissues. The pathophysiology involves acute and chronic inflammation and foreign body granuloma formation. Damage results from the impact, ischemia due to vascular compression, chemical inflammation, and secondary infection. Highly viscous substances (eg, grease) require higher injection pressures than paint or solvents.
Fuel and paint injections lead to the most severe inflammatory response with a high incidence of subsequent amputation. Grease- and oil-based compounds may lead to oleogranulomas with chronic fistula formation, scarring, and eventual loss of digit function.
Overall incidence of amputation approaches 48%.1 Morbidity is dependent to a large degree upon the material injected. Paint solvents appear to cause the greatest damage and result in amputation in 60-80% of the cases. Grease, the more common injectant, causes a less severe inflammatory response. Amputation is necessary in about 25% of these patients.2
These injuries are rare in women.
High-pressure hand injuries usually occur in young men while working, most often to their nondominant index finger. The average age at time of injury in one large review was 35 years (range, 16-65 y). These injuries occurred to the nondominant hand 76% of the time.2
Most injuries have resulted from grease guns, paint sprayers, or diesel fuel injectors. The cause of injury in one case report was from a high-pressure paint gun.6
Emergency department care for high-pressure hand injuries includes the following:
Refer these patients emergently to an experienced hand or orthopedic surgeon. Prompt surgical debridement optimizes tissue salvage.
The goal of therapy is to prevent infections. Prophylactic broad-spectrum antibiotics are indicated.
Therapy must cover all likely pathogens in the context of the clinical setting.
DOC; first-generation semisynthetic cephalosporin which, by binding to one or more penicillin-binding proteins, arrests bacterial cell wall synthesis and inhibits bacterial growth. Primarily active against skin flora, including Staphylococcus aureus.
1 g IV/IM q6-8h for 5-7 d
25-50 mg/kg/d IV/IM divided tid/qid for 5-7 d
Probenecid prolongs effect; aminoglycosides may increase renal toxicity; may yield false-positive urine dip test for glucose
Documented hypersensitivity
B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals
Adjust dose in renal impairment; superinfections and promotion of nonsusceptible organisms may occur with prolonged use or repeated therapy
Inhibits bacterial synthesis of dihydrofolic acid by competing with para-aminobenzoic acid, inhibiting folic acid synthesis and thus bacterial growth. Antibacterial activity of TMP-SMZ includes common urinary tract pathogens except Pseudomonas aeruginosa.
160 mg TMP or 800 mg SMZ PO q12h for 5-7 d
<2 months: Not recommended
Infants and children >2 months: 15-20 mg/kg/d (TMP dose) PO divided tid/qid for 5-7 d
May increase PT when used with warfarin (perform coagulation tests and adjust dose accordingly); coadministration with dapsone may increase blood levels of both drugs; diuretics increase incidence of thrombocytopenia purpura in elderly; may increase phenytoin levels; may potentiate effects of methotrexate in bone marrow depression; may increase hypoglycemic response to sulfonylureas; may increase levels of zidovudine
Documented hypersensitivity; megaloblastic anemia due to folate deficiency
Do not administer to infants <2 mo
C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus
Discontinue at first appearance of skin rash or sign of adverse reaction; obtain CBCs frequently; discontinue therapy if significant hematologic changes occur; goiter, diuresis, and hypoglycemia may occur with sulfonamides; prolonged IV infusions or high doses may cause bone marrow depression (if signs occur, give 5-15 mg/d leucovorin); caution in folate deficiency (eg, chronic alcoholics, elderly, those receiving anticonvulsant therapy, or those with malabsorption syndrome); hemolysis may occur in G-6-PD-deficient individuals; AIDS patients may not tolerate or respond; caution in renal or hepatic impairment (perform urinalyses and renal function tests during therapy); give fluids to prevent crystalluria and stone formation
Lincosamide useful as treatment against serious skin and soft-tissue infections caused by most staphylococci strains. Also effective against aerobic and anaerobic streptococci, except enterococci.
600-1200 mg/d IV/IM divided q6-8h for 5-7 d
20-40 mg/kg/d IV/IM divided tid/qid
Increases duration of neuromuscular blockade induced by tubocurarine and pancuronium; erythromycin may antagonize effects; antidiarrheals may delay absorption
Documented hypersensitivity; regional enteritis; ulcerative colitis; hepatic impairment; antibiotic-associated colitis
B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals
Adjust dose in severe hepatic dysfunction; no adjustment necessary in renal insufficiency; associated with severe and possibly fatal colitis
Treats susceptible bacterial infections of both gram-positive and gram-negative organisms, as well as infections caused by Mycoplasma, Chlamydia, and Rickettsia species. Inhibits bacterial protein synthesis by binding with 30S and possibly 50S ribosomal subunit(s) of susceptible bacteria.
250-500 mg PO q6h
25-50 mg/kg/d PO divided q6h
Bioavailability decreases with antacids containing aluminum, calcium, magnesium, iron, or bismuth subsalicylate; can decrease effects of oral contraceptives, causing breakthrough bleeding and increased risk of pregnancy; can increase hypoprothrombinemic effects of anticoagulants
Documented hypersensitivity; severe hepatic dysfunction
D - Fetal risk shown in humans; use only if benefits outweigh risk to fetus
Photosensitivity may occur with prolonged exposure to sunlight or tanning equipment; reduce dose in renal impairment; consider drug serum level determinations in prolonged therapy; use during tooth development (last one half of pregnancy through age 8 y) can cause permanent discoloration of teeth; Fanconilike syndrome may occur with outdated tetracyclines
Interferes with synthesis of cell wall mucopeptide during active multiplication, resulting in bactericidal activity against susceptible bacteria.
250-500 mg PO q8h; not to exceed 3 g/d
20-50 mg/kg/d PO divided q8h
Reduces efficacy of oral contraceptives
Documented hypersensitivity
B - Fetal risk not confirmed in studies in humans but has been shown in some studies in animals
Adjust dose in renal impairment
Verhoeven N, Hierner R. High-pressure injection injury of the hand: an often underestimated trauma: case report with study of the literature. Strategies Trauma Limb Reconstr. Apr 2008;3(1):27-33. [Medline].
Gonzalez R, Kasdan ML. High pressure injection injuries of the hand. Clin Occup Environ Med. 2006;5(2):407-11, ix. [Medline].
Vilke GM, Snyder B. High pressure paint spray gun injury. J Emerg Med. Aug 2002;23(2):203-4. [Medline].
Valentino M, Rapisarda V, Fenga C. Hand injuries due to high-pressure injection devices for painting in shipyards: circumstances, management, and outcome in twelve patients. Am J Ind Med. May 2003;43(5):539-42. [Medline].
Dailiana H, Kotsaki D, Varitimidis S, Moka S, Bakarozi M, Oikonomou K. Injection injuries: seemingly minor injuries with major consequences. Hippokratia. Jan 2008;12(1):33-6. [Medline].
Oktem F, Ocguder A, Altuntas N, Bozkurt M, Tellioglu AT. High-pressure paint gun injection injury of the hand: a case report. J Plast Reconstr Aesthet Surg. Jun 2009;62(6):e157-9. [Medline].
Kon M, Sagi A. High-pressure water jet injury of the hand. J Hand Surg [Am]. May 1985;10(3):412-4. [Medline].
Goetting AT, Carson J, Burton BT. Freon injection injury to the hand. A report of four cases. J Occup Med. Aug 1992;34(8):775-8. [Medline].
Almind M, Broeng L. A high velocity, high temperature injection injury. J Hand Surg [Br]. Apr 1993;18(2):249-50. [Medline].
Atkinson RE. Injection injuries of the hand: Caveat doctor. Hawaii Med J. Sep 1989;48(9):364-6, 395. [Medline].
Bekler H, Gokce A, Beyzadeoglu T. [Dissemination pathways in high-pressure injection injuries of the hand: an experimental animal model]. Acta Orthop Traumatol Turc. 2007;41(2):147-51. [Medline].
Bekler H, Gokce A, Beyzadeoglu T, Parmaksizoglu F. The surgical treatment and outcomes of high-pressure injection injuries of the hand. J Hand Surg Eur Vol. Aug 2007;32(4):394-9. [Medline].
Geller ER, Gursel E. A unique case of high-pressure injection injury of the hand. J Trauma. May 1986;26(5):483-5. [Medline].
Harter BT, Harter KC. High-pressure injection injuries. Hand Clin. Aug 1986;2(3):547-52. [Medline].
Hogan CJ, Ruland RT. High-pressure injection injuries to the upper extremity: a review of the literature. J Orthop Trauma. Jul 2006;20(7):503-11. [Medline].
Larsen JM, Bindiger A, Sherman R, Kuschner SH. Insecticide injection injuries to both hands: a case report. J Hand Surg [Am]. Nov 1992;17(6):1073-5. [Medline].
Lewis HG, Clarke P, Kneafsey B, Brennen MD. A 10-year review of high-pressure injection injuries to the hand. J Hand Surg [Br]. Aug 1998;23(4):479-81. [Medline].
Loveday I. High-pressure injection injuries. Emerg Nurse. Nov 2007;15(7):22-3. [Medline].
Luber KT, Rehm JP, Freeland AE. High-pressure injection injuries of the hand. Orthopedics. Feb 2005;28(2):129-32. [Medline].
Mizani MR, Weber BE. High-pressure injection injury of the hand. The potential for disastrous results. Postgrad Med. Jul 2000;108(1):183-5, 189-90. [Medline].
Neal NC, Burke FD. High-pressure injection injuries. Injury. Nov 1991;22(6):467-70. [Medline].
Schnall SB, Mirzayan R. High-pressure injection injuries to the hand. Hand Clin. May 1999;15(2):245-8, viii. [Medline].
Subramaniam RM, Clearwater GM. High-pressure water injection injury: emergency presentation and management. Emerg Med (Fremantle). Sep 2002;14(3):324-7. [Medline].
Vasilevski D, Noorbergen M, Depierreux M, Lafontaine M. High-pressure injection injuries to the hand. Am J Emerg Med. Nov 2000;18(7):820-4. [Medline].
hand injury, injection injury, high-pressure injection injury, grease gun injury, paint sprayer injury, diesel fuel injector injury, oleogranulomas, chronic fistula formation, chemical inflammation, finger amputation, fingertip injury, high pressure hand injury
Glen Vaughn, MD, Director, Department of Emergency Medicine, Defiance Hospital
Disclosure: Nothing to disclose.
Dan Danzl, MD, Chair, Department of Emergency Medicine, Professor, University of Louisville Hospital
Dan Danzl, MD is a member of the following medical societies: American Academy of Emergency Medicine, American College of Emergency Physicians, American Medical Association, Kentucky Medical Association, Society for Academic Emergency Medicine, and Wilderness Medical Society
Disclosure: Nothing to disclose.
Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: eMedicine Salary Employment
Eric L Legome, MD, Chair, Department of Emergency Medicine, St Vincent's Hospital Manhattan; Associate Professor, Department of Emergency Medicine, New York Medical College
Eric L Legome, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Emergency Medicine, American College of Emergency Physicians, Council of Emergency Medicine Residency Directors, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.
John D Halamka, MD, MS, Associate Professor of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center; Chief Information Officer, CareGroup Healthcare System and Harvard Medical School; Attending Physician, Division of Emergency Medicine, Beth Israel Deaconess Medical Center
John D Halamka, MD, MS is a member of the following medical societies: American College of Emergency Physicians, American Medical Informatics Association, Phi Beta Kappa, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.
Rick Kulkarni, MD, Assistant Professor of Surgery, Section of Emergency Medicine, Yale-New Haven Hospital
Rick Kulkarni, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Emergency Medicine, American College of Emergency Physicians, American Medical Association, American Medical Informatics Association, Phi Beta Kappa, and Society for Academic Emergency Medicine
Disclosure: WebMD Salary Employment
© 1994-
by Medscape.
All Rights Reserved
(http://www.medscape.com/public/copyright)